Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.
Access full-text PDFOpen Access
Check access options
Check access options
Feng, Lucy H
De Goede, Christian G
Sousa, Carlos de
AffiliationDubowitz Neuromuscular Centre, Institute of Child Health & Great Ormond Street Hospital, 30 Guilford Street, London WC1N 1EH, United Kingdom.
DNA Mutational Analysis
RNA Splice Sites
MetadataShow full item record
CitationGenotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. 2010, 20 (4):241-50 Neuromuscul. Disord.
JournalNeuromuscular disorders : NMD
AbstractMerosin deficient congenital muscular dystrophy 1A (MDC1A) results from mutations in the LAMA2 gene. We report 51 patients with MDC1A and examine the relationship between degree of merosin expression, genotype and clinical features. Thirty-three patients had absence of merosin and 13 showed some residual merosin. Compared to the residual merosin group, patients with absent merosin had an earlier presentation (<7days) (P=0.0073), were more likely to lack independent ambulation (P=0.0215), or require enteral feeding (P=0.0099) and ventilatory support (P=0.0354). We identified 33 novel LAMA2 mutations; these were distributed throughout the gene in patients with absent merosin, with minor clusters in exon 27, 14, 25 and 26 (55% of mutations). Patients with residual merosin often carried at least one splice site mutation and less frequently frameshift mutations. This large study identified novel LAMA2 mutations and highlights the role of immunohistochemical studies for merosin status in predicting clinical severity of MDC1A.
- Clinical and genomic characteristics of LAMA2 related congenital muscular dystrophy in a patients' cohort from Qatar. A population specific founder variant.
- Authors: Abdel Aleem A, Elsaid MF, Chalhoub N, Chakroun A, Mohamed KAS, AlShami R, Kuzu O, Mohamed RB, Ibrahim K, AlMudheki N, Osman O, Ross ME, ELalamy O
- Issue date: 2020 Jun
- Merosin-deficient congenital muscular dystrophy: A novel homozygous mutation in the laminin-2 gene.
- Authors: Turner C, Mein R, Sharpe C, Love DR
- Issue date: 2015 Dec
- Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1A.
- Authors: Khorrami A, Goleij P, Karamad V, Taheri E, Shadman B, Emami P, Jahangirzadeh G, Hajazimian S, Isazadeh A, Baradaran B, Heidari M
- Issue date: 2021 Nov
- Genetically confirmed patients with merosin-deficient congenital muscular dystrophy in China.
- Authors: Yuan J, Takashima H, Higuchi I, Arimura K, Li N, Zhao Z, Shen H, Hu J
- Issue date: 2008 Oct
- A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
- Authors: Gupta VA, Kawahara G, Myers JA, Chen AT, Hall TE, Manzini MC, Currie PD, Zhou Y, Zon LI, Kunkel LM, Beggs AH
- Issue date: 2012